Great Oaks Venture Capital

Great Oaks Venture Capital is a New York-based venture firm with a multi-stage thesis spanning seed through growth investing, with a generalist software focus that has historically included healthcare, fintech, consumer, and enterprise software. The greatoaksvc.com website confirms an established platform with selective check writing across multiple stages. For healthcare AI founders, Great Oaks is a credible generalist with healthcare exposure rather than a healthcare specialist; access depends on team, market, and category fit rather than sub-vertical thesis. Plausible check sizes vary by stage: 250K to 1.5M at seed and pre-seed, larger checks at later stages with selective follow-on. The firm participates in syndicated rounds and writes selective lead checks at the earliest stages. Founders building healthcare AI with strong B2B SaaS economics, healthcare-flavored consumer products with clear category leadership, or enterprise software with healthcare buyers should approach. Founders building deep biotech, regulated medical devices, or clinical AI requiring deep regulatory expertise should look at healthcare specialists. Entry path is LinkedIn outreach to partners with a sharp pitch, or warm introduction through New York founder networks and operator communities. The firm reads inbound and responds to substantive pitches. Diligence will be standard generalist seed and growth stage diligence: team, market, traction, defensibility. Expect a generalist read with light healthcare market context. Bring evidence of customer traction and clear category framing. The value-add includes New York network access, generalist board input on operational scaling, and follow-on capacity from a multi-stage platform. Realistic expectation is supportive generalist capital alongside thesis-aligned healthcare-specialist leads.